Literature DB >> 18164815

Chronic microinjection of valproic acid into the nucleus accumbens attenuates amphetamine-induced locomotor activity.

Wha Young Kim1, Seungwoo Kim, Jeong-Hoon Kim.   

Abstract

Amphetamine (AMPH)-induced hyper-locomotion has been well manifested in an animal model of psychiatric diseases such as drug addiction and bipolar disorder. In this study, we investigated the effects on AMPH-induced locomotor activity of chronically microinjected valproic acid into the nucleus accumbens (NAcc). Rats with guide cannular implanted bilaterally were divided into three groups and either saline or valproic acid (100 or 300 microg/0.5 microl/side) was microinjected into the NAcc once daily for 7 days. On day 8, half of each group received either saline or AMPH (1mg/kg, i.p.), respectively, and locomotor activity was measured for 2h. The increases of both horizontal locomotion and rearing by AMPH were attenuated in the rat pre-treated with valproic acid compared to saline in a dose-dependent manner. These results indicate that neuronal modifications in the NAcc induced by chronic valproic acid can modulate amphetamine-induced locomotor activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18164815     DOI: 10.1016/j.neulet.2007.12.005

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  25 in total

1.  Histone deacetylase and acetyltransferase inhibitors modulate behavioral responses to social stress.

Authors:  Katharine E McCann; Anna M Rosenhauer; Genna M F Jones; Alisa Norvelle; Dennis C Choi; Kim L Huhman
Journal:  Psychoneuroendocrinology       Date:  2016-10-26       Impact factor: 4.905

2.  Chronic valproate attenuates some, but not all, facets of mania-like behaviour in mice.

Authors:  Jordy van Enkhuizen; Mark A Geyer; Klaas Kooistra; Jared W Young
Journal:  Int J Neuropsychopharmacol       Date:  2012-11-20       Impact factor: 5.176

Review 3.  Transcriptional and epigenetic mechanisms of addiction.

Authors:  Alfred J Robison; Eric J Nestler
Journal:  Nat Rev Neurosci       Date:  2011-10-12       Impact factor: 34.870

Review 4.  Epigenetic regulation of memory by acetylation and methylation of chromatin: implications in neurological disorders, aging, and addiction.

Authors:  Nilkantha Sen
Journal:  Neuromolecular Med       Date:  2014-04-29       Impact factor: 3.843

5.  Early life stress exacerbates cognitive dysfunction induced by d-amphetamine: amelioration by valproic acid.

Authors:  Rose Mary Carvalho Pinheiro; Maria Noêmia Martins de Lima; Gabriel Rodrigo Fries; Vanessa Athaíde Garcia; Juliana Presti-Torres; Luis Henrique Hallmenschlager; Luisa Azambuja Alcalde; Rafael Roesler; Monica Levy Andersen; João Quevedo; Flávio Kapczinski; Nadja Schröder
Journal:  J Neural Transm (Vienna)       Date:  2012-01-05       Impact factor: 3.575

6.  Chronic treatment with lithium or valproate modulates the expression of Homer1b/c and its related genes Shank and Inositol 1,4,5-trisphosphate receptor.

Authors:  Andrea de Bartolomeis; Carmine Tomasetti; Maria Cicale; Pei-Xiong Yuan; Husseini K Manji
Journal:  Eur Neuropsychopharmacol       Date:  2012-01-14       Impact factor: 4.600

7.  Neuroanatomical profile of antimaniac effects of histone deacetylases inhibitors.

Authors:  Camila O Arent; Samira S Valvassori; Gabriel R Fries; Laura Stertz; Camila L Ferreira; Jéssica Lopes-Borges; Edemilson Mariot; Roger B Varela; Felipe Ornell; Flávio Kapczinski; Monica L Andersen; João Quevedo
Journal:  Mol Neurobiol       Date:  2011-03-22       Impact factor: 5.590

Review 8.  Regulation of chromatin states by drugs of abuse.

Authors:  Deena M Walker; Hannah M Cates; Elizabeth A Heller; Eric J Nestler
Journal:  Curr Opin Neurobiol       Date:  2014-12-06       Impact factor: 6.627

9.  The Epigenetic Mechanisms of Amphetamine.

Authors:  Talus J McCowan; Archana Dhasarathy; Lucia Carvelli
Journal:  J Addict Prev       Date:  2015-02-09

Review 10.  Epigenetic mechanisms in mood disorders: targeting neuroplasticity.

Authors:  D M Fass; F A Schroeder; R H Perlis; S J Haggarty
Journal:  Neuroscience       Date:  2013-01-30       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.